Journal Home > Volume 11 , Issue 3

Tea as the most consumed beverage in the world has received enormous attention for its promoting health benefits. The deleterious effect of α-dicarbonyls and AGEs formed in Maillard reaction is also a long-term challenge. The connection between the two topics was the main aim of this review, to address and update the antiglycation effect and mechanism of tea and tea polyphenols. By analyzing recent publications, we have covered across chemistry models, cell lines and animal studies. Tea polyphenols, particularly catechins, showed outstanding antiglycation effect by trapping α-dicarbonyl compounds and impeding AGEs formation. Reduction of carbonyl stress brought alleviation to aging, diabetes, and collagen related diseases or complications through regulation of RAGE expression and subsequent MAPK and TGF-β pathway. Therefore, tea polyphenols can serve as promising natural candidates in the treatment and/or prevention of nephropathy, retinopathy, hepatopathy, hyperglycemia and obesity among others, by their potent antiglycation effect. Further studies need to address on aspects like exact mechanisms, solution of detection obstacles, balance of practical usage and harmful effects such as potential flavor damage and toxicity in food, to gain a comprehensive understanding of antiglycation activities of tea polyphenols and its actual application.


menu
Abstract
Full text
Outline
About this article

Management of Maillard reaction-derived reactive carbonyl species and advanced glycation end products by tea and tea polyphenols

Show Author's information Yue Luoa,bJianan ZhangcChi-Tang Hoa( )Shiming Lib( )
Department of Food Science, Rutgers University, NJ 08901, USA
Hubei Key Laboratory of EFGI & RCU, Huanggang Normal University, Huanggang 438000, China
School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China

Abstract

Tea as the most consumed beverage in the world has received enormous attention for its promoting health benefits. The deleterious effect of α-dicarbonyls and AGEs formed in Maillard reaction is also a long-term challenge. The connection between the two topics was the main aim of this review, to address and update the antiglycation effect and mechanism of tea and tea polyphenols. By analyzing recent publications, we have covered across chemistry models, cell lines and animal studies. Tea polyphenols, particularly catechins, showed outstanding antiglycation effect by trapping α-dicarbonyl compounds and impeding AGEs formation. Reduction of carbonyl stress brought alleviation to aging, diabetes, and collagen related diseases or complications through regulation of RAGE expression and subsequent MAPK and TGF-β pathway. Therefore, tea polyphenols can serve as promising natural candidates in the treatment and/or prevention of nephropathy, retinopathy, hepatopathy, hyperglycemia and obesity among others, by their potent antiglycation effect. Further studies need to address on aspects like exact mechanisms, solution of detection obstacles, balance of practical usage and harmful effects such as potential flavor damage and toxicity in food, to gain a comprehensive understanding of antiglycation activities of tea polyphenols and its actual application.

Keywords: Tea polyphenols, Tea, Reactive carbonyl species, Advanced glycation end product, Maillard reaction

References(62)

[1]

J.A. Lin, C.H. Wu, G.C. Yen, Perspective of advanced glycation end products on human health, J. Agric. Food Chem. 66 (2018) 2065-2070. http://doi.org/10.1021/acs.jafc.7b05943

[2]

S. Rahbar, O. Blumenfeld, H.M. Ranney, Studies of an unusual hemoglobin in patients with diabetes mellitus, Biochem. Biophys. Res. Commun. 36 (1969) 838-843. http://doi.org/10.1016/0006-291x(69)90685-8

[3]

Y. Suematsu, S. Yamagishi, H. Saito, et al., A case of advanced gastric cancer with a pathological complete response after neoadjuvant chemotherapy(s-1/oxaliplatin), Gan To Kagaku Ryoho 43 (2016) 2225-2227

[4]

M.B. Manigrasso, J. Juranek, R. Ramasamy, et al., Unlocking the biology of rage in diabetic microvascular complications, Trends Endocrinol. Metab. 25 (2014) 15-22. http://doi.org/10.1016/j.tem.2013.08.002

[5]

V.P. Reddy, A. Beyaz, Inhibitors of the Maillard reaction and age breakers as therapeutics for multiple diseases, Drug Discov. 11 (2006) 646-654. http://doi.org/10.1016/j.drudis.2006.05.016

[6]

R. Singh, A. Barden, T. Mori, et al., Advanced glycation end-products: a review, Diabetologia 44 (2001) 129-146. http://doi.org/10.1007/s001250051591

[7]

Q.Y. Zhu, R.M. Hackman, J.L. Ensunsa, et al., Antioxidative activities of oolong tea, J. Agric. Food Chem. 50 (2002) 6929-6934. http://doi.org/10.1021/jf0206163

[8]

C.S. Yang, G. Chen, Q. Wu, Recent scientific studies of a traditional Chinese medicine, tea, on prevention of chronic diseases, J. Tradit. Complement. Med. 4 (2014) 17-23. http://doi.org/10.4103/2225-4110.124326

[9]

L. Xing, H. Zhang, R. Qi, et al., Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols, J. Agric. Food Chem. 67 (2019) 1029-1043. http://doi.org/10.1021/acs.jafc.8b06146

[10]

D. Sergi, H. Boulestin, F.M. Campbell, et al., The role of dietary advanced glycation end products in metabolic dysfunction, Mol. Nutr. Food Res. (2020) 1900934. http://doi.org/10.1002/mnfr.201900934

[11]

Y. Wang, C.T. Ho, Flavour chemistry of methylglyoxal and glyoxal, Chem. Soc. Rev. 41 (2012) 4140-4149. http://doi.org/10.1039/c2cs35025d

[12]

C. Henning, M.A. Glomb, Pathways of the Maillard reaction under physiological conditions, Glycoconj. J. 33 (2016) 499-512. http://doi.org/10.1007/s10719-016-9694-y

[13]

C. Sibbersen, M. Johannsen, Dicarbonyl derived post-translational modifications: chemistry bridging biology and aging-related disease, Essays Biochem. 64 (2020) 97-110. http://doi.org/10.1042/EBC20190057

[14]

J. Chaudhuri, Y. Bains, S. Guha, et al., The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality, Cell Metab. 28 (2018) 337-352. http://doi.org/10.1016/j.cmet.2018.08.014

[15]

J.P. Richard, Mechanism for the formation of methylglyoxal from triosephosphates, Biochem. Soc. Trans. 21 (1993) 549-553. http://doi.org/10.1042/bst0210549

[16]

M. Hellwig, D. Bunzel, M. Huch, et al., Stability of individual maillard reaction products in the presence of the human colonic microbiota, J. Agric. Food Chem. 63 (2015) 6723-6730. http://doi.org/10.1021/acs.jafc.5b01391

[17]

M.W. Poulsen, R.V. Hedegaard, J.M. Andersen, et al., Advanced glycation endproducts in food and their effects on health, Food Chem. Toxicol. 60 (2013) 10-37. http://doi.org/10.1016/j.fct.2013.06.052

[18]

P.J. Thornalley, The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life, Biochem. J. 269 (1990) 1-11. http://doi.org/10.1042/bj2690001

[19]

Y. Chen, S. Tang, Y. Chen, et al., Structure-activity relationship of procyanidins on advanced glycation end products formation and corresponding mechanisms, Food Chem. 272 (2019) 679-687. http://doi.org/10.1016/j.foodchem.2018.08.090

[20]

N. Rabbani, P.J. Thornalley, Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease, Biochem. Biophys. Res. Commun. 458 (2015) 221-226. http://doi.org/10.1016/j.bbrc.2015.01.140

[21]

N. Rabbani, P.J. Thornalley, Dicarbonyl proteome and genome damage in metabolic and vascular disease, Biochem. Soc. Trans. 42 (2014) 425-432. http://doi.org/10.1042/BST20140018

[22]

M.D. Del Castillo, A. Iriondo-DeHond, M. Iriondo-DeHond, et al., Healthy eating recommendations: good for reducing dietary contribution to the body's advanced glycation/lipoxidation end products pool? Nutr. Res. Rev. 34 (2020) 1-16. http://doi.org/10.1017/S0954422420000141

[23]

Y. Xie, X. Chen, Structures required of polyphenols for inhibiting advanced glycation end products formation, Curr. Drug Metab. 14 (2013) 414-431. http://doi.org/10.2174/1389200211314040005

[24]

Y. Jiao, J. He, Z. He, et al., Formation of Nε-(carboxymethyl)lysine and Nε-(carboxyethyl)lysine during black tea processing, Food Res. Int. 121 (2019) 738-745. http://doi.org/10.1016/j.foodres.2018.12.051

[25]

X. Wu, G. Zhang, M. Hu, et al., Molecular characteristics of gallocatechin gallate affecting protein glycation, Food Hydrocoll. 105 (2020) 105782. http://doi.org/10.1016/j.foodhyd.2020.105782

[26]

Y. Fujiwara, N. Kiyota, K. Tsurushima, et al., Natural compounds containing a catechol group enhance the formation of Nε-(carboxymethyl)lysine of the Maillard reaction, Free Radic. Biol. Med. 50 (2011) 883-891. http://doi.org/10.1016/j.freeradbiomed.2010.12.033

[27]

Y. Zhu, Y. Zhao, P. Wang, et al., Tea flavanols block advanced glycation of lens crystallins induced by dehydroascorbic acid, Chem. Res. Toxicol. 28 (2015) 135-143. http://doi.org/10.1021/tx500430z

[28]

X. Li, G.J. Liu, W. Zhang, et al., Novel flavoalkaloids from white tea with inhibitory activity against the formation of advanced glycation end products, J. Agric. Food Chem. 66 (2018) 4621-4629. http://doi.org/10.1021/acs.jafc.8b00650

[29]

Q. Wu, Q. Luo, J. Xiao, et al., Catechin-iron as a new inhibitor to control advanced glycation end-products formation during vinegar storage, LWT-Food Sci. Technol. 112 (2019) 108245. http://doi.org/10.1016/j.lwt.2019.06.012

[30]

C.Y. Lo, S. Li, D. Tan, et al., Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions, Mol. Nutr. Food Res. 50 (2006) 1118-1128. http://doi.org/10.1002/mnfr.200600094

[31]

S. Sang, X. Shao, N. Bai, et al., Tea polyphenol (–)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species, Chem. Res. Toxicol. 20 (2007) 1862-1870. http://doi.org/10.1021/tx700190s

[32]

T. Nakagawa, T. Yokozawa, K. Terasawa, et al., Protective activity of green tea against free radical- and glucose-mediated protein damage, J. Agric. Food Chem. 50 (2002) 2418-2422. http://doi.org/10.1021/jf011339n

[33]

J. Kim, C.S. Kim, M.K. Moon, et al., Epicatechin breaks preformed glycated serum albumin and reverses the retinal accumulation of advanced glycation end products, Eur. J. Pharmacol. 748 (2015) 108-114. http://doi.org/10.1016/j.ejphar.2014.12.010

[34]

S.C. Ho, S.P. Wu, S.M. Lin, et al., Comparison of anti-glycation capacities of several herbal infusions with that of green tea, Food Chem. 122 (2010) 768-774. http://doi.org/10.1016/j.foodchem.2010.03.051

[35]

A. Culetu, B. Fernandez-Gomez, M. Ullate, et al., Effect of theanine and polyphenols enriched fractions from decaffeinated tea dust on the formation of Maillard reaction products and sensory attributes of breads, Food Chem. 197 (2016) 14-23. http://doi.org/10.1016/j.foodchem.2015.10.097

[36]

Y. Li, L. Li, M.N. Lund, et al., Reduction of Nε-(carboxymethyl) lysine by (–)-epicatechin and (–)-epigallocatechin gallate: the involvement of a possible trapping mechanism by catechin quinones, Food Chem. 266 (2018) 427-434. http://doi.org/10.1016/j.foodchem.2018.06.009

[37]

Q. Wu, S. Tang, L. Zhang, et al., The inhibitory effect of the catechin structure on advanced glycation end product formation in alcoholic media, Food Funct. 11 (2020) 5396-5408. http://doi.org/10.1039/c9fo02887k

[38]

S. Mildner-Szkudlarz, A. Siger, A. Szwengiel, et al., Phenolic compounds reduce formation of Nε-(carboxymethyl)lysine and pyrazines formed by Maillard reactions in a model bread system, Food Chem. 231 (2017) 175-184. http://doi.org/10.1016/j.foodchem.2017.03.126

[39]

M. Sun, Z. Shen, Q. Zhou, et al., Identification of the antiglycative components of hong dou shan (taxus chinensis) leaf tea, Food Chem. 297 (2019) 124942. http://doi.org/10.1016/j.foodchem.2019.06.009

[40]

C. Sampath, Y. Zhu, S. Sang, et al., Bioactive compounds isolated from apple, tea, and ginger protect against dicarbonyl induced stress in cultured human retinal epithelial cells, Phytomed. 23 (2016) 200-213. http://doi.org/10.1016/j.phymed.2015.12.013

[41]

C. Liang, Y. Ren, H. Tan, et al., Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products, Br. J. Pharmacol. 158 (2009) 1865-1873. http://doi.org/10.1111/j.1476-5381.2009.00450.x

[42]

Z. Rasheed, A.N. Anbazhagan, N. Akhtar, et al., Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes, Arthritis Res. Ther. 11 (2009) R71. http://doi.org/10.1186/ar2700

[43]

N. Yamabe, T. Yokozawa, T. Oya, et al., Therapeutic potential of (–)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats, J. Pharmacol. Exp. Ther. 319 (2006) 228-236. http://doi.org/10.1124/jpet.106.107029

[44]

C. Sampath, M.R. Rashid, S. Sang, et al., Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via Nrf2 pathway in mice with high fat diet-induced obesity, Biomed. Pharmacother. 87 (2017) 73-81. http://doi.org/10.1016/j.biopha.2016.12.082

[45]

H.S. Alnahdi, N.S. Ayaz, A.M. Mohamed, et al., Modulating impacts of quercetin and/or lactoferrin on diabetic nephropathy and cardiomyopathy induced rats, Int. J. Pharma. Res. Allied Sci. 6 (2017) 128-137

[46]

P.V. Babu, K.E. Sabitha, P. Srinivasan, et al., Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats, Pharmacol. Res. 55 (2007) 433-440. http://doi.org/10.1016/j.phrs.2007.01.019

[47]

N. Yamabe, K.S. Kang, J.M. Hur, et al., Matcha, a powdered green tea, ameliorates the progression of renal and hepatic damage in type 2 diabetic oletf rats, J. Med. Food 12 (2009) 714-721. http://doi.org/10.1089/jmf.2008.1282

[48]

S.J. Yan, L. Wang, Z. Li, et al., Inhibition of advanced glycation end product formation by pu-erh tea ameliorates progression of experimental diabetic nephropathy, J. Agric. Food Chem. 60 (2012) 4102-4110. http://doi.org/10.1021/jf300347p

[49]

D. Lee, H.G. Son, Y. Jung, et al., The role of dietary carbohydrates in organismal aging, Cell Mol. Life Sci. 74 (2017) 1793-1803. http://doi.org/10.1007/s00018-016-2432-6

[50]

G. Chen, M. Xie, P. Wan, et al., Fuzhuan brick tea polysaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with modulation in the gut microbiota, J. Agric. Food Chem. 66 (2018) 2783-2795. http://doi.org/10.1021/acs.jafc.8b00296

[51]

L.G. Xiong, L.Y. Pan, Y.S. Gong, et al., Fuzhuan tea protects caenorhabditis elegans from glucose and advanced glycation end products via distinct pathways, J. Func. Foods 59 (2019) 148-155. http://doi.org/10.1016/j.jff.2019.05.040

[52]

M. Akagawa, T. Shigemitsu, K. Suyama, Production of hydrogen peroxide by polyphenols and polyphenol-rich beverages under quasi-physiological conditions, Biosci. Biotechnol. Biochem. 67 (2003) 2632-2640. http://doi.org/10.1271/bbb.67.2632

[53]

P. Yu, X.B. Xu, S.J. Yu, The effect of pH and amino acids on the formation of methylglyoxal in a glucose-amino acid model system, J. Sci. Food Agric. 97 (2017) 3159-3165. http://doi.org/10.1002/jsfa.8158

[54]

M.M. Poojary, W. Zhang, S.B. Olesen, et al., Green tea extract decreases Arg-derived advanced glycation endproducts but not Lys-derived AGEs in UHT milk during 1-year storage, J. Agric. Food Chem. 68 (2020) 14261-14273. https://doi.org/10.1021/acs.jafc.0c05995

[55]

I.A. Siddiqui, V.M. Adhami, D.J. Bharali, et al., Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate, Cancer Res. 69 (2009) 1712-1716. http://doi.org/10.1158/0008-5472.CAN-08-3978

[56]

B. Hu, Y. Ting, X. Yang, et al., Nanochemoprevention by encapsulation of (–)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability, Chem. Commun. (Camb) 48 (2012) 2421-2423. http://doi.org/10.1039/c2cc17295j

[57]

K.A. Clarke, T.P. Dew, R.E. Watson, et al., Green tea catechins and their metabolites in human skin before and after exposure to ultraviolet radiation, J. Nutr. Biochem. 27 (2016) 203-210. http://doi.org/10.1016/j.jnutbio.2015.09.001

[58]

C. Li, M.J. Lee, S. Sheng, et al., Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion, Chem. Res. Toxicol. 13 (2000) 177-184. http://doi.org/10.1021/tx9901837

[59]

M. Saeed, M. Naveed, M. Arif, et al., Green tea (Camellia sinensis) and L-theanine: medicinal values and beneficial applications in humans-a comprehensive review, Biomed. Pharmacother. 95 (2017) 1260-1275. http://doi.org/10.1016/j.biopha.2017.09.024

[60]

J.D. Lambert, M.J. Kennett, S. Sang, et al., Hepatotoxicity of high oral dose (–)-epigallocatechin-3-gallate in mice, Food Chem. Toxicol. 48 (2010) 409-416. http://doi.org/10.1016/j.fct.2009.10.030

[61]

M.U. Ahmed, S.R. Thorpe, J.W. Baynes, Identification of n epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein, J. Biol. Chem. 261 (1986) 4889-4894

[62]

E.R. Shin, W. Jung, M.K. Kim, et al., Identification of (−)-epigallocatechin (EGC) as a methylglyoxal (MGO)-trapping agent and thereby as an inhibitor of advanced glycation end product (AGE) formation, App. Biol. Chem. 61 (2018) 587-591. http://doi.org/10.1007/s13765-018-0384-2

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 11 December 2020
Revised: 22 January 2021
Accepted: 24 January 2021
Published: 04 February 2022
Issue date: May 2022

Copyright

© 2022 Beijing Academy of Food Sciences.

Acknowledgements

Acknowledgement

This research reported in this paper are funded by Hubei Science and Technology Plan Key Project (G2019ABA100).

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return